Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment
Sílvia Vidal, L. Puig, José-Manuel Carrascosa-Carrillo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6740-6740
Open Access | Times Cited: 25

Showing 25 citing articles:

The IL-17 family in diseases: from bench to bedside
Longjie Huangfu, Ruiying Li, Yamei Huang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 152
New insights into the function of Interleukin-25 in disease pathogenesis
Qingfang Yuan, Na Peng, Fan Xiao, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 24
Secukinumab for the treatment of adult-onset pityriasis rubra pilaris: a single-arm clinical trial with transcriptomic analysis
Blake Boudreaux, Thaís Pincelli, Puneet Bhullar, et al.
British Journal of Dermatology (2022) Vol. 187, Iss. 5, pp. 650-658
Open Access | Times Cited: 32
Interleukin inhibitors and the associated risk of candidiasis
Sabir Khan, Hazrat Bilal, Muhammad Nadeem Khan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Discovery of an Oral, Rule of 5 Compliant, Interleukin 17A Protein–Protein Interaction Modulator for the Potential Treatment of Psoriasis and Other Inflammatory Diseases
Mark David Andrews, Kevin N. Dack, Marcel J. de Groot, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 13, pp. 8828-8842
Closed Access | Times Cited: 20
Interleukin 17 RA and RC gene polymorphisms and increased preeclampsia risk: Single and combined genetic analysis
Mohammad Amin Norouzi, Danial Jahantigh, Forough Forghani, et al.
Human Immunology (2025) Vol. 86, Iss. 2, pp. 111250-111250
Closed Access
Neuronal Mechanisms of Psoriatic Itch: Role of IL17R/ERK/TRPV4 Signaling Pathway
Qiaojuan Zhang, Minji Jang, Fabiana C. Dias, et al.
Journal of Investigative Dermatology (2025)
Open Access
Escherichia coli aggravates inflammatory response in mice oral mucositis through regulating Th17/Treg imbalance
Jia Liu, Wenhui Xia, Juehua Cheng, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
IL17RA genetic variants are associated with susceptibility and severity of psoriasis
Camila C. De Alcantara, Edna Maria Vissoci Reiche, Cássio Rafael Moreira, et al.
Human Immunology (2025) Vol. 86, Iss. 4, pp. 111329-111329
Closed Access
Recent update on immunopathogenesis of psoriasis
Seema Chhabra, Sunil Dogra, Keshav Sharma, et al.
Indian Journal of Dermatology (2022) Vol. 67, Iss. 4, pp. 360-373
Open Access | Times Cited: 13
The Role of Tumor Microenvironment in the Pathogenesis of Sézary Syndrome
Denis Miyashiro, Bruno de Castro e Souza, Marina Passos Torrealba, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 936-936
Open Access | Times Cited: 11
Safety, tolerability, pharmacokinetics and efficacy of HB0017, a humanized monoclonal antibody that targets interleukin-17A, in healthy participants and patients with moderate-to-severe plaque psoriasis
Congjun Jiang, Yu Du, X J Liu, et al.
British Journal of Dermatology (2023) Vol. 190, Iss. 1, pp. 28-36
Closed Access | Times Cited: 6
Bimekizumab in the Treatment of Plaque Psoriasis: Focus on Patient Selection and Perspectives
Gemma Camiña‐Conforto, Laura Mateu Arrom, A. López‐Ferrer, et al.
Patient Preference and Adherence (2023) Vol. Volume 17, pp. 1541-1549
Open Access | Times Cited: 3
Interleukin 25 and its biological features and function in intestinal diseases
Wei Jiang, Zehui Wang, Jun Zhang, et al.
Central European Journal of Immunology (2022) Vol. 47, Iss. 4, pp. 362-372
Open Access | Times Cited: 5
Levels of IL-23/IL-17 Axis in Plasma and Gingival Tissue of Periodontitis Patients According to the New Classification
Ruth Rodríguez‐Montaño, Alondra del Carmen Ruiz Gutiérrez, Vianeth María del Carmen Martínez‐Rodríguez, et al.
Applied Sciences (2022) Vol. 12, Iss. 16, pp. 8051-8051
Open Access | Times Cited: 4
Narciclasine induces colon carcinoma cell apoptosis by inhibiting the IL-17A/Act1/TRAF6/NF-κB signaling pathway
Huiming Deng, Qiang Liu, Siman Yu, et al.
Genes & Diseases (2023) Vol. 11, Iss. 5, pp. 100938-100938
Open Access | Times Cited: 2
Erythrodermic Psoriasis Successfully Treated With Brodalumab: A Case Series
F. Mota, P. Mendes-Bastos
Actas Dermo-Sifiliográficas (2023) Vol. 114, Iss. 6, pp. 547-549
Open Access | Times Cited: 1
Causal Relationships between IL-17C and Psoriasis and Atopic Dermatitis in European Populations: A Mendelian Randomization Analysis
Ya Li, Jun Cai, Huimin Chong
Research Square (Research Square) (2024)
Open Access
Interleukin 17F Gene Polymorphism as a Potential Protective Factor in the Immunopathology of Ocular Toxoplasmosis
Danilo Donizete da Silva, Fábio Batista Frederico, Mariana Previato, et al.
Parasite Immunology (2024) Vol. 46, Iss. 5
Closed Access
Advances in biologic therapy for the treatment of moderate to severe psoriasis: a systematic review
Josselyn Nicole Villarreal Enríquez, Mateo Daniel Fabara Vera, Vanessa Carolina Batallas Salazar, et al.
Ibero-American Journal of Health Science Research (2024) Vol. 4, Iss. 1, pp. 134-142
Open Access
NETosis in autoimmune diseases with focus on psoriasis
Daniela Elena Costea, Monica Neagu, Carolina Constantin, et al.
Reviews in Biological and Biomedical Sciences (2024) Vol. 5, Iss. 1, pp. 29-42
Closed Access
Brodalumab: Six-Year US Pharmacovigilance Report
Mark Lebwohl, John Koo, April W. Armstrong, et al.
Dermatology and Therapy (2024)
Open Access
SMALL-MOLECULE PROTEIN-PROTEIN INTERACTION MODULATORS (PPIm) OF THE IL-17 AND IL-17R COMPLEXES
Mark David Andrews, Marcel J. de Groot, Kevin N. Dack
Medicinal chemistry reviews (2022), pp. 221-238
Closed Access | Times Cited: 1
Immunopathological inflammation in patients with psoriasis is effectively reduced by bimekizumab treatment targeting simultaneously IL-17A and IL-17F
Jan Krejsek
Dermatologie pro praxi (2023) Vol. 17, Iss. 1, pp. 16-19
Closed Access
[Artículo Traducido] Psoriasis eritrodérmica exitosamente tratada con brodalumab: serie de casos
Filipe Mota, Pedro Mendes‐Bastos
Actas Dermo-Sifiliográficas (2023) Vol. 114, Iss. 6, pp. T547-T549
Open Access
Page 1

Scroll to top